Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Comparative interactions of factor IX and factor IXa with human platelets.

S S Ahmad1, R Rawala-Sheikh, P N Walsh

  • 1Department of Medicine, Temple University School of Medicine, Philadelphia, Pennsylvania 19140.

The Journal of Biological Chemistry
|February 25, 1989
PubMed
Summary

Platelets bind factor IX and factor IXa via specific sites. Factor VIII and factor X enhance factor IXa binding affinity on activated platelets, crucial for factor X activation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Digital Health in Clinical Oncology.

Clinical oncology (Royal College of Radiologists (Great Britain))·2025
Same author

The Association between Constitutional Knee Alignment and the Horizontal Orientation of the Ankle Joint Line.

Acta chirurgiae orthopaedicae et traumatologiae Cechoslovaca·2022
Same author

Tissue engineering approaches for the repair and regeneration of the anterior cruciate ligament: towards 3D bioprinted ACL-on-chip.

European cells & materials·2022
Same author

Molecular evidence and hematological alterations associated with the occurrence of coronavirus in domestic dogs in Pakistan.

Tropical biomedicine·2021
Same author

Sero-prevalence of Hepatitis B and C Virus from rural areas of northern Punjab (Sargodha District), Pakistan.

Tropical biomedicine·2021
Same author

Science in Focus: Genomic Instability and its Implications for Clinical Cancer Care.

Clinical oncology (Royal College of Radiologists (Great Britain))·2018

Area of Science:

  • Hematology
  • Biochemistry
  • Molecular Biology

Background:

  • Platelets play a critical role in hemostasis and thrombosis.
  • Coagulation factors, including factor IX and factor IXa, interact with platelets to regulate blood clotting.
  • Understanding these interactions is essential for developing targeted anticoagulant therapies.

Purpose of the Study:

  • To investigate the binding characteristics of factor IX and factor IXa to activated platelets.
  • To determine the number and affinity of binding sites for factor IX and factor IXa on platelets.
  • To elucidate the influence of cofactors like factor VIII and factor X on these binding interactions.

Main Methods:

  • Utilized gel-filtered platelets and radiolabeled factor IX and factor IXa for binding assays.

Related Experiment Videos

  • Employed CaCl2 and alpha-thrombin to activate platelets and induce ligand binding.
  • Conducted competition studies with various coagulation proteins to identify specific binding sites.
  • Analyzed saturation binding data to determine binding site stoichiometry and affinity (Kd).

    • Main Results:

    • Factor IX and factor IXa bind to thrombin-activated platelets in a time- and calcium-dependent manner.
    • Approximately 300 low-affinity binding sites per platelet are shared by factor IX and factor IXa in the absence of factors VIII and X.
    • Factor Xa binding affinity increases approximately 5-fold in the presence of factors VIII and X on activated platelets.
    • Factor VIII and factor X significantly enhance the binding of factor IXa to activated platelets.

    Conclusions:

    • Thrombin-activated platelets possess specific binding sites for factor IX and factor IXa.
    • The interaction of factor IXa with activated platelets is modulated by factors VIII and X.
    • These findings highlight the importance of platelet-factor interactions in the coagulation cascade, particularly in factor X activation.